Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Liu, Haiying ^a   Liu, Yunfeng ^a   Wang, Luxia ^b   Xu, Dexing ^b   Lin, Bingliang ^c   Zhong, Renqian ^d   Gong, Sitang ^a   Podda, Mauro ^e,f   Invernizzi, Pietro ^e,g  

^a GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

^b Liuhuaqiao Hospital   (China)

^c THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; MITOCHONDRION ANTIBODY; AUTOANTIBODY;

ABNORMAL LABORATORY RESULT; ADULT; AGED; ANTIBODY SCREENING; ARTICLE; ATTITUDE TO HEALTH; CHINA; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE QUALITY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT REFERRAL; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; SEX RATIO; ADOLESCENT; BILIARY CIRRHOSIS; COMPARATIVE STUDY; FOLLOW UP; HEALTH STATUS; IMMUNOLOGY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MITOCHONDRION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; IMMUNOBLOTTING; LIVER CIRRHOSIS, BILIARY; MALE; MASS SCREENING; MIDDLE AGED; MITOCHONDRIA; PREVALENCE; YOUNG ADULT;

EID: 77956481303     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-100     Document Type: Article

References (35)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005, 353(12):1261-1273. 10.1056/NEJMra043898, 16177252.
2. Invernizzi P, Selmi C, Ranftler C, Podda M, Wesierska-Gadek J. Antinuclear antibodies in primary biliary cirrhosis. Semin Liver Dis 2005, 25(3):298-310. 10.1055/s-2005-916321, 16143945.
3. Farrell GC. Primary biliary cirrhosis in Asians: less common than in Europeans, but just as depressing. J Gastroenterol Hepatol 2008, 23(4):508-511. 10.1111/j.1440-1746.2008.05379.x, 18397481.
4. Gross RG, Odin JA. Recent advances in the epidemiology of primary biliary cirrhosis. Clin Liver Dis 2008, 12(2):289-303. viii, 10.1016/j.cld.2008.02.001, 18456181.
5. Invernizzi P. Geoepidemiology of autoimmune liver diseases. J Autoimmun 34(3):J300-306. 10.1016/j.jaut.2009.12.002, 20036105.
6. Liu HY, Deng AM, Zhang J, Zhou Y, Yao DK, Tu XQ, Fan LY, Zhong RQ. Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis. World J Gastroenterol 2005, 11(26):4108-4110.
7. Liang Y, Yang Z, Li C, Zhu Y, Zhang L, Zhong R. Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis. Clin Exp Med 2008, 8(1):1-7. 10.1007/s10238-008-0149-z, 18385934.
8. Shen M, Zhang F, Zhang X. Primary biliary cirrhosis complicated with interstitial lung disease: a prospective study in 178 patients. J Clin Gastroenterol 2009, 43(7):676-679. 10.1097/MCG.0b013e31818aa11e, 19247207.
9. Su CW, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, Lee PC, Lee SD, Wu JC. Natural history and prognostic factors of primary biliary cirrhosis in Taiwan: a follow-up study up to 18 years. Liver Int 2008, 28(9):1305-1313. 10.1111/j.1478-3231.2008.01715.x, 18346129.
10. Wong GL, Law FM, Wong VW, Hui AY, Chan FK, Sung JJ, Chan HL. Health-related quality of life in Chinese patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2008, 23(4):592-598. 10.1111/j.1440-1746.2007.05092.x, 17645470.
11. Wong RK, Lim SG, Wee A, Chan YH, Aung MO, Wai CT. Primary biliary cirrhosis in Singapore: evaluation of demography, prognostic factors and natural course in a multi-ethnic population. J Gastroenterol Hepatol 2008, 23(4):599-605. 10.1111/j.1440-1746.2007.05058.x, 17645483.
12. Moteki S, Leung PS, Coppel RL, Dickson ER, Kaplan MM, Munoz S, Gershwin ME. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 1996, 24(1):97-103. 10.1002/hep.510240117, 8707289.
13. Gershwin ME, Coppel RL, Bearer E, Peterson MG, Sturgess A, Mackay IR. Molecular cloning of the liver-specific rat F antigen. J Immunol 1987, 139(11):3828-3833.
14. Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Gershwin ME. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007, 45(3):659-665. 10.1002/hep.21583, 17326160.
15. Invernizzi P, Lleo A, Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis 2007, 27(2):161-172. 10.1055/s-2007-979469, 17520516.
16. Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009, 33(1):12-16. 10.1016/j.jaut.2009.03.005, 19356902.
17. Vergani D, Alvarez F, Bianchi FB, Cancado EL, Mackay IR, Manns MP, Nishioka M, Penner E. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004, 41(4):677-683. 10.1016/j.jhep.2004.08.002, 15464251.
18. Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008, 14(21):3374-3387. 10.3748/wjg.14.3374, 2716592, 18528935.
19. European Association For The Study Of The L EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2009, 50(2):227-242. 10.1016/j.jhep.2008.10.001, 19054588, European Association For The Study Of The L.
20. Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978, 379(2):103-112. 10.1007/BF00432479, 150690.
21. Yao G. Stress on clinical research of primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 2002, 10(5):325.
22. Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol 2002, 97(9):2402-2407. 10.1111/j.1572-0241.2002.06019.x, 12358264.
23. Kim WR, Lindor KD, Locke GR, Therneau TM, Homburger HA, Batts KP, Yawn BP, Petz JL, Melton LJ, Dickson ER. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology 2000, 119(6):1631-1636. 10.1053/gast.2000.20197, 11113084.
24. Myers RP, Shaheen AA, Fong A, Burak KW, Wan A, Swain MG, Hilsden RJ, Sutherland L, Quan H. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology 2009, 50(6):1884-1892. 10.1002/hep.23210, 19821525.
25. Pla X, Vergara M, Gil M, Dalmau B, Cistero B, Bella RM, Real J. Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. Eur J Gastroenterol Hepatol 2007, 19(10):859-864. 10.1097/MEG.0b013e328277594a, 17873609.
26. Rautiainen H, Salomaa V, Niemela S, Karvonen AL, Nurmi H, Isoniemi H, Farkkila M. Prevalence and incidence of primary biliary cirrhosis are increasing in Finland. Scand J Gastroenterol 2007, 42(11):1347-1353. 10.1080/00365520701396034, 17918011.
27. Magrini A, Nicodemo S, Puoti C. Hospital prevalence of asymptomatic primary biliary cirrhosis: 4-year study based on analysis of 4468 consecutive in-patients. Liver 1996, 16(6):377-379.
28. Sakugawa H, Nakasone H, Nakayoshi T, Yamashiro T, Maeshiro T, Kobashigawa K, Kinjo F, Saito A, Zukeran H, Nakanuma Y, Ohba K. Epidemiology of primary biliary cirrhosis among women with elevated gamma-glutamyl transpeptidase levels in Okinawa, Japan. Hepatol Res 2003, 26(4):330-336. 10.1016/S1386-6346(03)00167-0, 12963434.
29. Delgado J, Sperber AD, Novack V, Delgado B, Edelman L, Gaspar N, Krugliak P, Odes S, Jotkowitz AB, Faszczyk M, Fich A. The epidemiology of primary biliary cirrhosis in southern Israel. Isr Med Assoc J 2005, 7(11):717-721.
30. James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom?. Hepatology 1999, 30(2):390-394. 10.1002/hep.510300213, 10421645.
31. Sood S, Gow PJ, Christie JM, Angus PW. Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology 2004, 127(2):470-475. 10.1053/j.gastro.2004.04.064, 15300579.
32. Turchany JM, Uibo R, Kivik T, Van de Water J, Prindiville T, Coppel RL, Gershwin ME. A study of antimitochondrial antibodies in a random population in Estonia. Am J Gastroenterol 1997, 92(1):124-126.
33. Kisand KE, Metskula K, Kisand KV, Kivik T, Gershwin ME, Uibo R. The follow-up of asymptomatic persons with antibodies to pyruvate dehydrogenase in adult population samples. J Gastroenterol 2001, 36(4):248-254. 10.1007/s005350170111, 11324728.
34. Jiang XH, Zhong RQ, Fan XY, Hu Y, An F, Sun JW, Kong XT. Characterization of M2 antibodies in asymptomatic Chinese population. World J Gastroenterol 2003, 9(9):2128-2131.
35. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 2008, 7(8):626-630. 10.1016/j.autrev.2008.06.009, 18603021.